PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS. GenApp [Internet]. 2018 Dec. 25 [cited 2026 Nov. 14];2(2):51-6. Available from: https://genapp.ba/editions/index.php/journal/article/view/108